Advertisement
Correspondence| Volume 28, ISSUE 12, P1072-1073, December 15, 1990

Drug versus behavioral treatment of obsessive-compulsive disorder

DOI:https://doi.org/10.1016/0006-3223(90)90615-9
Drug versus behavioral treatment of obsessive-compulsive disorder
Previous ArticleResponse
Next ArticleResponse
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Katz R.J.
        • De Veaugh-Geiss J.
        • Landau P.
        Clomipramine in obsessive-compulsive disorder.
        Biol Psychiatry. 1990; 28: 401-414
        • Marks I.M.
        • de Albuquerque A.
        • Cottraux J.
        • et al.
        The “efficacy” of alprazolam in panic disorder and agoraphobia: A critique of recent reports (Letter).
        Arch Gen Psychiatry. 1989; 46: 668-669
        • Marks I.M.
        • O'Sullivan G.
        Drugs and psychological treatments for agoraphobia/panic and OCD: A review.
        Br J Psychiatry. 1988; 153: 650-658
        • Marks I.M.
        • Stern C.S.
        • Mawson D.
        • et al.
        Clomipramine and exposure for obsessive-compulsive rituals.
        Br J Psychiatry. 1980; 136: 1-25
        • Marks I.M.
        • Lelliott P.
        • Basoglu M.
        • et al.
        Clomipramine, self-exposure, and therapist-aided exposure for obsessive-compulsive rituals.
        Br J Psychiatry. 1988; 152: 522-534
        • Monteiro W.O.
        • Noshirvani H.F.
        • Marks I.M.
        • Lelliott P.T.
        Anorgasmia from clomipramia in OCD: A controlled trial.
        Br J Psychiatry. 1987; 151: 107-112
        • O'Sullivan G.
        • Marks I.M.
        Long-term outcome of phobic and OCD after exposure: A review.
        in: Handbook of Anxiety. Elsevier, Amsterdam1990
        • Oxtoby A.
        • Jones A.
        • Robinson M.
        Is your “double-blind” design truly double-blind?.
        Br J Psychiatry. 1989; 155: 700-701
        • Pato M.T.
        • Zohar-Kadouch R.
        • Zohar J.
        • Murphy D.L.
        Return of symptoms after discontinuation of clomipramine in OCD.
        Am J Psychiatry. 1988; 145: 1521-1525

      Article info

      Identification

      DOI: https://doi.org/10.1016/0006-3223(90)90615-9

      Copyright

      © 1990 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX